Related references
Note: Only part of the references are listed.RHOA mutation may be associated with diffuse-type gastric cancer progression, but is it gain or loss?
Masahiro Maeda et al.
GASTRIC CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Alexander A. Svoronos et al.
CANCER RESEARCH (2016)
Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma
Raheleh Roudi et al.
TUMOR BIOLOGY (2016)
Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells
Xue-Bin Zhang et al.
TUMOR BIOLOGY (2016)
Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2
Huaidong Wang et al.
ONCOTARGET (2016)
MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA
Zhuo Chen et al.
MEDICAL SCIENCE MONITOR (2016)
Dysregulation of microRNA biogenesis machinery in cancer
Akiko Hata et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2
W. Ruoming et al.
CANCER GENE THERAPY (2015)
Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer
Raheleh Roudi et al.
CANCER BIOMARKERS (2014)
Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
Miwako Kakiuchi et al.
NATURE GENETICS (2014)
miRBase: annotating high confidence microRNAs using deep sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2014)
Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA
Kuo-Wei Chang et al.
ORAL ONCOLOGY (2013)
Rho GTPase regulation by miRNAs and covalent modifications
Ming Liu et al.
TRENDS IN CELL BIOLOGY (2012)
Advanced gastric cancer - Slow but steady progress
Derek G. Power et al.
CANCER TREATMENT REVIEWS (2010)
Data Analysis in Flow Cytometry: The Future Just Started
Enrico Lugli et al.
CYTOMETRY PART A (2010)
Implication of microRNAs in drug resistance for designing novel cancer therapy
Fazlul H. Sarkar et al.
DRUG RESISTANCE UPDATES (2010)
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
Xi Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance
Yuanyuan Zhang et al.
MEDICAL ONCOLOGY (2010)
Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
N. Bhatnagar et al.
CELL DEATH & DISEASE (2010)
RhoA Regulates G(1)-S Progression of Gastric Cancer Cells by Modulation of Multiple INK4 Family Tumor Suppressors
Siyuan Zhang et al.
MOLECULAR CANCER RESEARCH (2009)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity
N Liu et al.
CLINICAL CANCER RESEARCH (2004)
Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR -: art. no. e36
MW Pfaffl et al.
NUCLEIC ACIDS RESEARCH (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
